Print Friendly, PDF & Email

WASHINGTON, Sept 26 (Reuters) – When Michael Marks and John Wang stepped off the board of directors of Jiangbo Pharmaceuticals JGBO.O in June, they said goodbye to the Chinese company with a 23-page resignation letter complaining of months of unanswered questions, unpaid bills and management deception. Full Article